Two of the greatest threats to patient health, hypertension (HTN) and heart failure (HF), are discussed in meticulous detail in this second installment of our Comprehensive Cardiovascular Pharmacology series. Beginning with an overview of national and international guidelines for the assessment and staging of HTN, the session then analyzes the most effective pharmacologic treatment pathways for patients with this condition, including those in special populations. Special attention is given to the prevention and treatment of hypertensive crises, including a thorough discussion on the proper administration of vasodilators.
This session then turns to the key concepts and compensatory mechanisms of HF, followed by a review of national staging guidelines for patients with HF. Pharmacologic agents in the treatment of mild to the most severe cases of HF are presented in detail, and the session closes with an examination of the various devices used in mechanical circulatory support.